ASCENT INDUSTRIES CO. Segments Disclosure
| Year Ended December 31, 2025 | ||||||||||||||||||||
| (in thousands) | Specialty Chemicals | Corporate & Other1 | Continuing Operations | |||||||||||||||||
| Net sales | $ | 74,942 | $ | — | $ | 74,942 | ||||||||||||||
| Cost of goods sold - material | 34,068 | — | 34,068 | |||||||||||||||||
Cost of goods sold - other2 | 20,350 | — | 20,350 | |||||||||||||||||
| Depreciation | 3,312 | — | 3,312 | |||||||||||||||||
| Gross profit | 17,212 | — | 17,212 | |||||||||||||||||
| Research and development | — | 71 | 71 | |||||||||||||||||
Selling, general and administrative expense3 | 12,590 | 10,371 | 22,961 | |||||||||||||||||
| Depreciation & amortization | 779 | 353 | 1,132 | |||||||||||||||||
| Acquisition costs and other | 92 | 639 | 731 | |||||||||||||||||
| Asset impairments | — | 1,622 | 1,622 | |||||||||||||||||
| Gain on lease modification | — | (2,278) | (2,278) | |||||||||||||||||
| Interest (income) expense, net | 52 | (764) | (712) | |||||||||||||||||
| Income taxes | — | 22 | 22 | |||||||||||||||||
| Other (income) expense, net | (1) | (752) | (753) | |||||||||||||||||
| Net income (loss) | $ | 3,700 | $ | (9,284) | $ | (5,584) | ||||||||||||||
| Identifiable assets | $ | 37,303 | $ | 74,634 | $ | 111,937 | ||||||||||||||
| Capital expenditures | $ | 1,385 | $ | 159 | $ | 1,544 | ||||||||||||||
Geographic sales4 | ||||||||||||||||||||
| United States | $ | 70,495 | $ | — | $ | 70,495 | ||||||||||||||
| Mexico | 1,186 | — | 1,186 | |||||||||||||||||
| Canada | 785 | — | 785 | |||||||||||||||||
| Honduras | 711 | — | 711 | |||||||||||||||||
| Colombia | 627 | — | 627 | |||||||||||||||||
| The Netherlands | 597 | — | 597 | |||||||||||||||||
| Costa Rica | 266 | — | 266 | |||||||||||||||||
| Japan | 90 | — | 90 | |||||||||||||||||
| Guatemala | 53 | — | 53 | |||||||||||||||||
| Singapore | 44 | — | 44 | |||||||||||||||||
| Bahamas | 37 | — | 37 | |||||||||||||||||
| Taiwan | 31 | — | 31 | |||||||||||||||||
| Thailand | $ | 20 | $ | — | $ | 20 | ||||||||||||||
| Year Ended December 31, 2024 | ||||||||||||||||||||
| (in thousands) | Specialty Chemicals | Corporate & Other1 | Continuing Operations | |||||||||||||||||
| Net sales | $ | 80,763 | $ | — | $ | 80,763 | ||||||||||||||
| Cost of goods sold - material | 40,903 | — | 40,903 | |||||||||||||||||
Cost of goods sold - other2 | 25,040 | 485 | 25,525 | |||||||||||||||||
| Depreciation | 3,631 | 12 | 3,643 | |||||||||||||||||
| Gross profit | 11,189 | (497) | 10,692 | |||||||||||||||||
Selling, general and administrative expense3 | 8,672 | 11,185 | 19,857 | |||||||||||||||||
| Depreciation & amortization | 874 | 168 | 1,042 | |||||||||||||||||
| Acquisition costs and other | 476 | 186 | 662 | |||||||||||||||||
| Gain on lease modification | — | (67) | (67) | |||||||||||||||||
| Interest expense, net | 75 | 342 | 417 | |||||||||||||||||
| Income taxes | — | 1,806 | 1,806 | |||||||||||||||||
| Other (income) expense, net | (1) | (447) | (448) | |||||||||||||||||
| Net income (loss) | $ | 1,093 | $ | (13,670) | $ | (12,577) | ||||||||||||||
| Identifiable assets | $ | 38,928 | $ | 46,298 | $ | 85,226 | ||||||||||||||
| Capital expenditures | $ | 1,120 | $ | — | $ | 1,120 | ||||||||||||||
| Geographic sales | ||||||||||||||||||||
| United States | $ | 75,564 | $ | — | $ | 75,564 | ||||||||||||||
| Mexico | 1,880 | — | 1,880 | |||||||||||||||||
| Canada | 1,750 | — | 1,750 | |||||||||||||||||
| Honduras | 1,212 | — | 1,212 | |||||||||||||||||
| Costa Rica | 194 | — | 194 | |||||||||||||||||
| Argentina | 47 | — | 47 | |||||||||||||||||
| Singapore | 44 | — | 44 | |||||||||||||||||
| Taiwan | 30 | — | 30 | |||||||||||||||||
| Guatemala | 22 | — | 22 | |||||||||||||||||
| Brazil | 11 | — | 11 | |||||||||||||||||
| Other | $ | 9 | $ | — | $ | 9 | ||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 3, 2026 | Showing above |
| 2024 | Mar 4, 2025 | |
| 2023 | Apr 1, 2024 | |
| 2022 | Mar 31, 2023 | |
| 2021 | Mar 29, 2022 | |
| 2020 | Mar 9, 2021 | |
| 2019 | Mar 6, 2020 | |
| 2018 | Mar 18, 2019 | |
| 2017 | Mar 13, 2018 | |
| 2016 | Mar 14, 2017 | |
| 2015 | Mar 30, 2016 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.